Yearly Publication Trends - pharmacogenomics

Year	Publication Count
2024	253
2023	579
2022	345
2021	318
2020	288
2019	195
2018	131
2017	144
2016	158
2015	117
2014	150

Relevant Publications

Affective Disorders, Pharmacogenomics, and Psychiatric Illness-Related Cardiometabolic Problems.

Issue Release: 2024

Frequency of pharmacogenomic variation and medication exposures among All of Us Participants.

Issue Release: 2024

Genetic Variations Affect Chemotherapy Outcomes: A Role of the Spindle-assembly Checkpoint.

Issue Release: 2024

A Second Space Age Spanning Omics, Platforms, and Medicine Across Orbits.

Issue Release: 2024

Association of Glycoprotein IIIa PlA1/A2 Polymorphism with Risk of Stroke: Updated Meta-Analysis.

Issue Release: 2024

Pharmacogenomics: Challenges and Future.

Issue Release: 2024

Reprint of: Implementation of depression management by ambulatory care pharmacists in the primary care setting.

Issue Release: 2024

Genome-wide association study of therapeutic response to statin drugs in cardiovascular disease.

Issue Release: 2024

Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve.

Issue Release: 2024

Universal Targeted Haplotyping by Droplet Digital PCR Sequencing and Its Applications in Noninvasive Prenatal Testing and Pharmacogenetics Analysis.

Issue Release: 2024

New diagnostic technologies in laboratory medicine: Potential benefits and challenges.

Issue Release: 2024

Stability of Anticoagulation Following Acenocoumarin in Stroke Patients: Role of Pharmacogenomics and Acquired Factors.

Issue Release: 2024

Implementation of clopidogrel pharmacogenetic clinical decision support for a preemptive return of results program.

Issue Release: 2024

The complex web of obesity: from genetics to precision medicine.

Issue Release: 2024

Identification of drug responsive enhancers by predicting chromatin accessibility change from perturbed gene expression profiles.

Issue Release: 2024

From Sugar Spikes to Pressure Peaks: Navigating the World of Diabetes, Hypertension, Obesity, and Kidney Health.

Issue Release: 2024

Contradiction in Star-Allele Nomenclature of Pharmacogenes between Common Haplotypes and Rare Variants.

Issue Release: 2024

Individualized Pharmacotherapy Utilizing Genetic Biomarkers and Novel In Vitro Systems As Predictive Tools for Optimal Drug Development and Treatment.

Issue Release: 2024

Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient.

Issue Release: 2024

Frequency of pharmacogenomic variants affecting efficacy and safety of anti-cancer drugs in a south Asian population from Sri Lanka.

Issue Release: 2024

What is Regulatory Approval?

What is Generic Competition?

What is a New Drug Application (NDA)?

How Can Cellular Stress Be Measured?

What are the Implications for Pharma Companies?

What Strategies do Brand-Name Companies Use to Delay Generic Entry?

Why Are Clinical Trials Important?

How Does Pharma Play a Role in Chronic Conditions?

How Can Pharma Companies Improve Patient Education?

What Are the Therapeutic Approaches to Mitigate Cellular Stress?

Partnered Content Networks

Relevant Topics